Literature DB >> 3833541

Tartrate-resistant acid phosphatase in human alveolar macrophages.

T Efstratiadis, D W Moss.   

Abstract

Tartrate-resistant acid phosphatase has been extracted from human alveolar macrophages, in which its specific activity is 10-fold that in whole lung. The apparent identity of the alveolar macrophage isoenzyme with that associated with osteoclasts suggests that both types of cell belong to the mononuclear phagocyte system. Within this system, expression of tartrate-resistant acid phosphatase appears to accompany certain kinds of differentiation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3833541     DOI： 10.1159/000469376

Source DB:  PubMed          Journal:  Enzyme        ISSN： 0013-9432


  6 in total

1.  Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.

Authors:  B S Moonga; D W Moss; A Patchell; M Zaidi
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

2.  Localization of tartrate-resistant acid phosphatase in human placenta.

Authors:  A J Janckila; H Yaziji; S C Lear; A W Martin; L T Yam
Journal:  Histochem J       Date:  1996-03

3.  Histochemical and immunological demonstration of purple acid phosphatase in human and bovine alveolar macrophages.

Authors:  J Schindelmeiser; P Schewe; T Zonka; D Münstermann
Journal:  Histochemistry       Date:  1989

4.  Histochemical investigations on the localization of the purple acid phosphatase in the bovine spleen.

Authors:  J Schindelmeiser; D Münstermann; H Witzel
Journal:  Histochemistry       Date:  1987

5.  Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.

Authors:  R Torres; C de la Piedra; A Rapado
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

6.  Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils.

Authors:  Morwenna Y Porter; Katy E Routledge; Sheena E Radford; Eric W Hewitt
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.